• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

Professional Introduction to 2-Chloro-7-methoxyquinoline-3-carbaldehyde (CAS No. 68236-20-4)

2-Chloro-7-methoxyquinoline-3-carbaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 68236-20-4, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its versatile structural framework and potential biological activities. This compound belongs to the quinoline class of molecules, which is well-documented for its broad spectrum of pharmacological properties, including antimicrobial, antimalarial, and anticancer effects. The presence of both chloro and methoxy substituents in its structure enhances its reactivity and functionality, making it a valuable scaffold for further chemical modifications and derivatization.

The chemical structure of 2-Chloro-7-methoxyquinoline-3-carbaldehyde consists of a quinoline core substituted at the 2-position with a chloro group and at the 7-position with a methoxy group. The aldehyde functionality at the 3-position provides a reactive site for various chemical transformations, such as condensation reactions, reduction, or oxidation, which are commonly employed in the synthesis of more complex molecules. This structural motif is particularly interesting because it allows for the exploration of novel pharmacophores that could exhibit enhanced biological activity compared to parent quinoline derivatives.

In recent years, there has been an increasing interest in quinoline derivatives as potential therapeutic agents. The 2-Chloro-7-methoxyquinoline-3-carbaldehyde scaffold has been investigated for its ability to interact with biological targets such as enzymes and receptors involved in disease pathways. For instance, studies have shown that quinoline-based compounds can modulate kinases and other enzymes that are aberrantly expressed in cancer cells, leading to inhibition of tumor growth and proliferation. The chloro and methoxy substituents are thought to play a crucial role in determining the binding affinity and selectivity of these compounds toward their target proteins.

One of the most compelling aspects of 2-Chloro-7-methoxyquinoline-3-carbaldehyde is its potential as a precursor in the synthesis of more complex molecules with tailored biological activities. Researchers have utilized this compound as a building block to develop novel inhibitors targeting specific disease-related pathways. For example, derivatives of this compound have been explored for their anti-inflammatory properties by interacting with cyclooxygenase (COX) enzymes or other inflammatory mediators. The aldehyde group at the 3-position can be further functionalized into amides, esters, or other heterocycles, which can enhance the solubility and bioavailability of the final drug candidates.

The synthesis of 2-Chloro-7-methoxyquinoline-3-carbaldehyde typically involves multi-step organic reactions starting from readily available quinoline precursors. Common synthetic routes include chlorination at the 2-position followed by methylation at the 7-position, with subsequent formylation at the 3-position to introduce the aldehyde functionality. Advances in synthetic methodologies have enabled more efficient and scalable production processes for this compound, making it more accessible for research purposes. These improvements have also allowed for better control over regioselectivity and yield optimization during synthesis.

In academic research, 2-Chloro-7-methoxyquinoline-3-carbaldehyde has been employed as a key intermediate in several high-profile studies investigating novel drug candidates. For instance, researchers have synthesized various derivatives of this compound and evaluated their efficacy against infectious diseases caused by pathogenic bacteria and parasites. The structural features of these derivatives have been fine-tuned to improve their pharmacokinetic properties while maintaining or enhancing their biological activity. Such efforts are part of broader initiatives to address emerging infectious diseases and drug-resistant pathogens.

The pharmaceutical industry has also shown interest in leveraging 2-Chloro-7-methoxyquinoline-3-carbaldehyde as part of their drug discovery programs. Its unique structural features make it an attractive candidate for further development into new therapeutic agents targeting various diseases. Collaborative efforts between academic institutions and pharmaceutical companies have led to innovative approaches in synthesizing analogs with improved potency and reduced toxicity profiles. These collaborations are essential for translating laboratory findings into clinical applications that benefit patients worldwide.

From a medicinal chemistry perspective, 2-Chloro-7-methoxyquinoline-3-carbaldehyde represents an excellent example of how structural modifications can influence biological activity. The interplay between electronic effects induced by chloro and methoxy groups, along with steric hindrance provided by these substituents, can significantly impact how these compounds interact with biological targets. Understanding these relationships is crucial for designing molecules that not only exhibit high affinity but also demonstrate favorable pharmacokinetic properties such as oral bioavailability and metabolic stability.

Future directions in research involving 2-Chloro-7-methoxyquinoline-3-carbaldehyde may focus on exploring its potential in treating neurological disorders or chronic inflammatory conditions where quinoline-based compounds have shown promise. Additionally, computational methods such as molecular docking simulations could be employed to predict new binding interactions between this compound and disease-related proteins before experimental validation becomes necessary. Such computational approaches can accelerate drug discovery processes by identifying promising candidates early on while minimizing resource expenditure on less viable leads.

In conclusion,2-Chloro-7-methoxyquinoline-3-carbaldehyde (CAS No,68236-20-4) is a versatile heterocyclic compound with significant potential in pharmaceutical applications due to its unique structural features and reactivity profile。 Its role as an intermediate in synthesizing novel drug candidates underscores its importance in medicinal chemistry research。 As our understanding of disease mechanisms continues to evolve， so too will our ability to design molecules like this one that target specific pathological processes effectively。 The continued exploration of quinoline derivatives promises exciting developments across multiple therapeutic areas， offering hope for improved treatments against some of today's most challenging diseases。

• 281208-98-8(2-Chloro-6-ethoxyquinoline-3-carboxaldehyde)
• 23872-25-5(2-chloro-5-methoxy-1H-indole-3-carbaldehyde)
• 68236-23-7(2-Chloro-6,7-dimethoxyquinoline-3-carbaldehyde)
• 151772-24-6(2,4-Dichloro-6-methoxyquinoline-3-carbaldehyde)
• 332382-81-7(6-Chloro1,3dioxolo4,5-gquinoline-7-carbaldehyde)
• 129798-05-6(2-chloro-7-ethoxyquinoline-3-carbaldehyde)
• 73568-28-2(2-Chloro-8-methoxyquinoline-3-carbaldehyde)
• 73568-29-3(2-Chloro-6-methoxyquinoline-3-carbaldehyde)
• 68236-25-9(2-Chloro-5,6,7-trimethoxy-3-quinolinecarbaldehyde)
• 132118-45-7(2-Chloro-7-methoxy-3-methylquinoline)